PCLAF and cancer: Second, WEB-2086 capability to abrogate the PAF-mediated signal will contribute to reduce growth, tumorigenic and metastatic potential of transformed cells, and impact also cancer microenvironment by contrasting neoangiogenesis (Bussolati et al, 2000).